These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 37193711)

  • 1. HUNK inhibits epithelial-mesenchymal transition of CRC via direct phosphorylation of GEF-H1 and activating RhoA/LIMK-1/CFL-1.
    Han X; Jiang S; Gu Y; Ding L; Zhao E; Cao D; Wang X; Wen Y; Pan Y; Yan X; Duan L; Sun M; Zhou T; Liu Y; Hu H; Ye Q; Gao S
    Cell Death Dis; 2023 May; 14(5):327. PubMed ID: 37193711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polarity-regulating kinase partitioning-defective 1b (PAR1b) phosphorylates guanine nucleotide exchange factor H1 (GEF-H1) to regulate RhoA-dependent actin cytoskeletal reorganization.
    Yamahashi Y; Saito Y; Murata-Kamiya N; Hatakeyama M
    J Biol Chem; 2011 Dec; 286(52):44576-84. PubMed ID: 22072711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypoxia inhibits HUNK kinase activity to induce epithelial-mesenchymal transition.
    Jiang S; Han X; Zhao Z; Song D; Cheng S; Liu T; Zhao X; Gu Y; Duan L; Gao S
    Biochem Biophys Res Commun; 2023 Nov; 681():271-275. PubMed ID: 37793312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NDR2 kinase contributes to cell invasion and cytokinesis defects induced by the inactivation of RASSF1A tumor-suppressor gene in lung cancer cells.
    Keller M; Dubois F; Teulier S; Martin APJ; Levallet J; Maille E; Brosseau S; Elie N; Hergovich A; Bergot E; Camonis J; Zalcman G; Levallet G
    J Exp Clin Cancer Res; 2019 Apr; 38(1):158. PubMed ID: 30979377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vincristine enhances amoeboid-like motility via GEF-H1/RhoA/ROCK/Myosin light chain signaling in MKN45 cells.
    Eitaki M; Yamamori T; Meike S; Yasui H; Inanami O
    BMC Cancer; 2012 Oct; 12():469. PubMed ID: 23057787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. mTORC1 and mTORC2 regulate EMT, motility, and metastasis of colorectal cancer via RhoA and Rac1 signaling pathways.
    Gulhati P; Bowen KA; Liu J; Stevens PD; Rychahou PG; Chen M; Lee EY; Weiss HL; O'Connor KL; Gao T; Evers BM
    Cancer Res; 2011 May; 71(9):3246-56. PubMed ID: 21430067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GEF-H1 over-expression in hepatocellular carcinoma promotes cell motility via activation of RhoA signalling.
    Cheng IK; Tsang BC; Lai KP; Ching AK; Chan AW; To KF; Lai PB; Wong N
    J Pathol; 2012 Dec; 228(4):575-85. PubMed ID: 22847784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The epidermal growth factor receptor mediates tumor necrosis factor-alpha-induced activation of the ERK/GEF-H1/RhoA pathway in tubular epithelium.
    Kakiashvili E; Dan Q; Vandermeer M; Zhang Y; Waheed F; Pham M; Szászi K
    J Biol Chem; 2011 Mar; 286(11):9268-79. PubMed ID: 21212278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Guanine nucleotide exchange factor-H1 regulates cell migration via localized activation of RhoA at the leading edge.
    Nalbant P; Chang YC; Birkenfeld J; Chang ZF; Bokoch GM
    Mol Biol Cell; 2009 Sep; 20(18):4070-82. PubMed ID: 19625450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HUNK phosphorylates EGFR to regulate breast cancer metastasis.
    Williams CB; Phelps-Polirer K; Dingle IP; Williams CJ; Rhett MJ; Eblen ST; Armeson K; Hill EG; Yeh ES
    Oncogene; 2020 Jan; 39(5):1112-1124. PubMed ID: 31597954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GEF-H1 modulates localized RhoA activation during cytokinesis under the control of mitotic kinases.
    Birkenfeld J; Nalbant P; Bohl BP; Pertz O; Hahn KM; Bokoch GM
    Dev Cell; 2007 May; 12(5):699-712. PubMed ID: 17488622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased expression of GEF-H1 promotes colon cancer progression by RhoA signaling.
    Cao J; Yang T; Tang D; Zhou F; Qian Y; Zou X
    Pathol Res Pract; 2019 May; 215(5):1012-1019. PubMed ID: 30846413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Central role of the exchange factor GEF-H1 in TNF-α-induced sequential activation of Rac, ADAM17/TACE, and RhoA in tubular epithelial cells.
    Waheed F; Dan Q; Amoozadeh Y; Zhang Y; Tanimura S; Speight P; Kapus A; Szászi K
    Mol Biol Cell; 2013 Apr; 24(7):1068-82. PubMed ID: 23389627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HUNK suppresses metastasis of basal type breast cancers by disrupting the interaction between PP2A and cofilin-1.
    Quintela-Fandino M; Arpaia E; Brenner D; Goh T; Yeung FA; Blaser H; Alexandrova R; Lind EF; Tusche MW; Wakeham A; Ohashi PS; Mak TW
    Proc Natl Acad Sci U S A; 2010 Feb; 107(6):2622-7. PubMed ID: 20133759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contribution of guanine exchange factor H1 in phorbol ester-induced apoptosis.
    Chang YC; Lee HH; Chen YJ; Bokoch GM; Chang ZF
    Cell Death Differ; 2006 Dec; 13(12):2023-32. PubMed ID: 16601754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR-29c mediates epithelial-to-mesenchymal transition in human colorectal carcinoma metastasis via PTP4A and GNA13 regulation of β-catenin signaling.
    Zhang JX; Mai SJ; Huang XX; Wang FW; Liao YJ; Lin MC; Kung HF; Zeng YX; Xie D
    Ann Oncol; 2014 Nov; 25(11):2196-2204. PubMed ID: 25193986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of guanine nucleotide exchange factor-H1 in complement-mediated RhoA activation in glomerular epithelial cells.
    Mouawad F; Aoudjit L; Jiang R; Szaszi K; Takano T
    J Biol Chem; 2014 Feb; 289(7):4206-18. PubMed ID: 24356971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypericin-mediated photodynamic therapy inhibits metastasis and EMT of colorectal cancer cells by regulating RhoA-ROCK1 signaling pathway.
    Hu J; Wen X; Song J
    Photochem Photobiol Sci; 2024 Jul; 23(7):1361-1372. PubMed ID: 38865066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CSRP2 suppresses colorectal cancer progression
    Chen L; Long X; Duan S; Liu X; Chen J; Lan J; Liu X; Huang W; Geng J; Zhou J
    Theranostics; 2020; 10(24):11063-11079. PubMed ID: 33042270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Claudin-2 suppresses GEF-H1, RHOA, and MRTF, thereby impacting proliferation and profibrotic phenotype of tubular cells.
    Dan Q; Shi Y; Rabani R; Venugopal S; Xiao J; Anwer S; Ding M; Speight P; Pan W; Alexander RT; Kapus A; Szászi K
    J Biol Chem; 2019 Oct; 294(42):15446-15465. PubMed ID: 31481470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.